chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I did not have an adverse reaction. I tested positive for COVID-19 on 07/23/2022 and tested positive again on 08/01/2022. I went to several emergency room and urgent care centers before anyone recommended a COVID-19 test. My children recommended for me to take a COVID-19 vaccine. I have been very sick with COVID-19 and I am an kidney transplant patient. I had a fever, chills, headache, nausea, nigh sweats, diarrhea and very tired. I was afraid I was going to lose my transplant. As of today, I still have a cough and I feel weak but I do try to continue to do things.
Patients caregiver informed faculty that patient experienced seizure approximately 48 hours after receiving vaccination. Patient was hospitalized and appears to be recovering.
Transferred to ED. Fever, Tachypnea, CoughWheeze & Tachycardia
had seizure like episode, went unresponsive < 30 sec, arms flexed, pt vomited
Seizures seen 3/19 had been having episodes of thrashing head observe. 3/21 sxs worse, eye rolling, arms clonic - admit. EEG neurology consult. (Mother states did after 4 months shot also), office  none noticed.  07/24/2007 MR received for DOS 3/21-22/2007. Infant presented with abnormal head  movements increasing in frequency. Began having seizures after 4 month shots, and have increased since 6 month shots 5 days ago. Impression:  Sandifer Syndrome.  Consider possibility of seizure disorder
lightheadedness/ tingling sensation in head, fatigue, loose stools, sore throat, nasal congestion, dry itchy skin. all started about a week after vaccination. patient evaluated one week after symptom onset. no concerning findings
T101, inflamed at site and warm to touch, 11/15 usual shot pain, 11/16 slight pain still, 11/17 inflamed an temp went to patient first DX with cellulitis antibiotics given 10 d supply.
Patient was vaccinated at 9:20, answered no to the pre-vaccination questionnaire. At time of vaccination, patient's are swelled / induration on left deltoid muscle. Bled slightly, but stated she was taking blood thinners. Returned to check on pt and to give her an ice pack to place on her arm. Asked pt how she felt, stated she was feeling fine. Spoke to provider, who recommended we bring her back to an exam room to get her vitals. Upon walking back to room, pt was shaky, unsteady, and had slurred speech. Reported that she had several mini strokes in Dec. 2021 and seizures in March 2022.  Initially FAST positive for slurred speech, negative for facial droop. Pt does have history of series of mini strokes in December 2021.  Positive FAST second check 0955, slight droop L. side of face, speech problems, unsteady on feet. Called emergency at 0956. Pt received COVID vaccine Pt starting having symptoms of stroke at 0940. FAST test positive at 0945 for speech impairment, and at 0955 for minor facial droop. BP elevated at 191/61. Initially discussed meeting air support and discovered speaking with emergency dispatch that for some reason conditions didn't allow helicopters to come at this time. Unknown reasons for this decision. Pt would have to wait here and wait for medic support which would be up to 30 minutes longer, and then air support would be delayed unknown period of time. Pt departed with EMTs to hospital to meet air support at hospital.
Sore arm, but adverse reaction was being lightheaded to the point I passed out for a few minutes.  Within 20 minutes of waking and standing, I fell and passed out or passed out and fell.
Patient developed fever of 104 and a 10 minute febrile siezure 12 days after receiving MMR and Varivax.  She also had a mild Varicella rash at that time.  I saw her the day after symptoms began.  She had fever over the next 24 hours but did not have further siezures.  She was fully recovered by 48 hours after onset and only had a resolving Varicella rash at that time.
Dizziness; Headaches; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), HEADACHE (Headaches) and MYALGIA (Body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), HEADACHE (Headaches) and MYALGIA (Body aches). At the time of the report, DIZZINESS (Dizziness), HEADACHE (Headaches) and MYALGIA (Body aches) had not resolved.            Concomitant medications were not provided.  Treatment information was not provided.
Increasing pain and decreasing range of motion to right shoulder in days/weeks following injection. Diagnosed with bursitis by occupational health physician.
Soreness at site of injection for a few days. Took ibuprofen as needed. Resolved without sequelae. (Vaccine (yellow fever) was diluted with 1.5 ml saline instead at 3 ml saline. Pt received 0.5 ml.)
Initial unsolicited report received from a non-healthcare professional on 19-Dec-2017. This case involves a 74 years old female patient, who was vaccinated once with a 0.5 ml dose of FLUZONE HD(batch number: UI808AA, expiry date: 28-Feb-2018, dose in series and route of administration was not reported) in left deltoid on 09-Nov-2017. Previous medication included vaccine FLUVIRIN. Patient's medication history and concomitant medications were not reported. On an unknown date, after receiving the vaccination, the patient experienced limited left arm movement. On an unknown date, patient was seen by her primary provider. Lab data were not reported. Corrective treatment included 10 physical therapy sessions ordered by patient's primary provider. Event outcome was reported as recovering. List of documents held by sender: none.
swelling of feet & hands-hives-seen in ER given epi & cortisone according to parent;
After second vaccine  El3246 developed flu like symptoms lasting up to 3 hrs this re occurred every 3 days  continuously for  9 months. Symptoms were headache, nausea, chills, joint pain . Stomach distress diagnosed with gastritis relieved by PPI . Booster vaccine iFH8030 11/20/21 3 hrs post injection severe left knee pain lasting 12 hrs. Followed by random joint pains in hands, back, neck. Flu like symptoms again tested  PCR negative  x 3 . I am a health care RN wearing a KN 95 12hrs.. a day. Basically I have not felt well since second vaccine . Currently experiencing daily chills, sometimes sneezing, lung pain and cough, no temperature  elevation ever.  I never know if I am experiencing  a new viral exposure daily-then symptoms dissipate after several hours.
HIGH FEVER AND PROSTATION SINCE THE PREVIOUS NIGHT; VOMITED TWICE AND AT THE TIME OF THE EXAMINATION ENTERED MY OFFICE ON HIS MOTHERS ARMS COMPLETELY LIMP AND HAD FINE TREMORS ON ALL EXTREMITIES. AFTER 10-15 MINUTES OF HIS STAY IN THE OFFICE, GRADUALLY RECOVERED CONSCIOUSNESS. THE REMAINER OF HIS PHYSICAL EXAM, INCLUDING HTE NEURO EXAM WERE NORMAL. SUBSEQUENTLY DEVELOPED SPASTIC QUADRIPLEGIA. UNDERWENT EXTENSIVE TESTING BY SEVERAL PEDIATRIC NEUROLOGISTS (EEG'S, MRI'S, BLOOD TESTS, ETC.). 4/24/06 Received medical records from PCP which reveal pt had uneventful birth w/Apgars of 8&9, followed by mild jaundice.  Pt very cranky w/fever, vomiting & tremors s/p 2nd DTP vax on 4/89.  Parents noted speech delay. 1991 thought to have a seizure after being hospitalized for severe bilateral maxillary sinusitis & periorbital cellulitis in 4/91.  After that, patient began to experience difficulty walking which  continued to progress.  CT scans & MRI's were WNL. In 1992 dx w/dystonia & hyperreflexia & leg weakness continued to progress despite intensive PT/OT.  1995 dx w/progressive spino-cerebellarl disorder after CT scan showed abnormality in white matter area known to control legs.  Started on Sinemet & had some slight improvement.  Now walks only minimally & w/great difficulty per PCP & w/use of crutches.  Pt had been in Portugal for approx 10 years & only just returned to USA 2/2006./ss
Administered vaccine from vials that may have been compromised; Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021 at 2:51 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021 at 2:43 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 02-Mar-2021 at 2:51 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 02-MAR-2021, Excursion time was 9 AM, temp was 27 , total doses given for the day was 177, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 24-FEB-2021, vial was moved to clinic on 02-MAR-2021. 16 vials were moved to clinic. Vaccine BUD date was 26-MAR-2021.  Vial was stored on cooler 1 ,on 02-MAR-2021, Excursion duration At 9 AM: 27 , 10 AM: 29, 11 AM: 32, 12 PM: 33, 1PM : 36, 2 PM : 35, 3 PM: 36  4 PM: 37 and 5 PM: 37   On 30-Mar-2021, Excursion time was 9 AM, temp was 33 , total doses given for the day was 173, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 30-Mar-2021. 3 vial was moved to clinic. Vaccine BUD date was 22-Apr-2021.  Vial was stored on cooler 1 , on 30-Mar-2021, Excursion duration At 9 AM: 33, 10 AM: 36, 11 AM:36, 12 PM:40, 1PM : 40, 2 PM : 39, 3 PM: 38, 4 PM: 40 and 5 PM : 40.  Vials only punctured right before administration  Concomitant products were not provided.  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.    Treatment medications were not reported
This spontaneous report was received from a pharmacist regarding to a 15 years old patient of unknown gender. The patient's concurrent conditions, concomitant medications, other pertinent medical history, drug reactions and allergies were not provided. On 27-JUL-2018, the patient was vaccinated with the first dose of VAQTA (lot #, expiration date, strength and route of administration were not provided) for prophylaxis. On 21-JAN-2019 (reported as 6 days too early), the patient received the second dose in the hepatitis A vaccination series with HAVRIX lot # 79D57 with expiration date 26-JUL-2020 (strength and route of administration were not provided) for prophylaxis; which was considered an interchange of vaccine products. No adverse effect was reported. By the reporting time, it was unknown if the patient recovered from the interchange of vaccine products. The causality assessment was not provided.
24SEP90: w/in 8-10 hrs of being vaccinated, pt developed influenza-type sx; sx resolved w/in 5 days; No known tx required;
started getting sick; she had pain before on her leg but with the first shot it intensified; she had pain before on her leg but with the first shot it intensified/Pain; back pain; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. Medical history included ongoing pain in extremity (she had pain before on her leg but with the first shot it intensified). The patient's concomitant medications were not reported. The patient experienced started getting sick , she had pain before on her leg but with the first shot it intensified, she had pain before on her leg but with the first shot it intensified/pain, back pain on an unspecified date. it was reported during report 1 about herself this caller reported information about her sister who she reported also had the Pfizer shot. Caller mentioned that her sister had the Pfizer Shot and had side effects. She would have to ask her sister who started getting sick but that was to be expected and then got better the next day. She was the only one except for this one sister who she thinks was having a side effect. Caller was the only one having side effects within she would say 2 weeks. Her sister started having a pain, she had pain before on her leg but with the first shot it intensified. Then it got mild so she though it was related to her back pain and whatever. They took care of the back but she was still having the front. So then when she got the second shot she told the nurse her pain had increased and she said now it was getting pretty, she was been putting ice and stuff like that she got her shots really early, this was like months later. The outcome for all events was recovering.   Information about the Lot/batch number has been requested.
Information has been received from a physician concerning a male who was vaccinated with PNEUMOVAX and a day later he experienced body aches and soreness. Concomitant therapy included influenza virus vaccine *unspecified). The patient's outcome was not reported. The patient sought unspecified medical attention. Additional information has been requested.
1.2 ml of diluent was added to the vaccine vial instead of 1.8 ml making it a slightly higher dose than authorized
I had the expected 24-48 hours of injection site tenderness on my upper right extremity after the  injection. No other symptoms. Then, eight days after, I woke up to a swollen, tender and VERY itchy injection site. No swollen lymph nodes detected.  No other symptoms.
pt recvd vax 10AM 19APR95 went to beach afterwards p/got home 130PM devel facial swelling & hives devel on face & body-vomited twice & wheezing; mom took pt to ER;
Parents noticed altered LOC x 1 day later in car ride. Child was watching a movie in the car 7/9/2017: ER---admitted. Summary: Patient is a 11 Y male presented to the emergency room with altered mental mental status earlier and then had a tonic-clonic seizure in the emergency room. There was some concern that he was having abnormal movements in the car on the way up here. He was moving his head wasn't following commands appropriately. Patient was sedated in the ER because of the seizures Procedures done: MRI was normal lumbar pressure was normal blood work was normal.
My doctor detected a heart murmur in a recent physical. Other than that my heart has been completely normal. I haven't been able to get in for additional medical testing so I'm waiting for further testing at this time. The other issue since I've taken the vaccines is numbness and tingling in the tips of my fingers. It results in cracking and the skin peeling. Neither of these have ever happened in my entire life. The skin cracking and peeling is very painful and I've been to the doctor twice for this, as well as a telehealth visit and a visit with a dermatologist and they do not know the cause of this.
Moderna's COVID-19 Bivalent Booster was given to a patient younger than 18 years of age (patient is 17 years and 6 months old). No adverse symptoms or signs have been reported from the patient as of 9/30/2022.
Itching around entire hairline, for 3 days. Both ears itched and swelled, for 3 days. April 14 - April 16 (Never happened in my lifetime)     - This happened after 2nd shot also.  May 22 - May 24
Friday patient came down with fever and chills, felt very weak and had body ache. Later that day, Her arm began hurting and she had a knot that swelled up at the injection site. Her arm pit was quite painful as well. She is still a bit tender, but mostly recovered at this time.
Starting 12/27/2021 developed tachycardia, heart rate up to 180. Ambulance called. Also diagnosed with rhinovirus. Patient has not recovered from tachycardia. HR 90-150?s. Dizziness. Unable to eat, severe anxiety. 3 emergency room visits and admission on 2/21/22 for shaking, tachycardia and severe anxiety. Still hospitalized as of date of this report.
Hives on arms, neck and left shoulder, as well as his face. Hives appeared 1-2 hrs. after vaccines were administered. Hives resolved with BENADRYL 1/2 tsp q4 hrs for 24 hr time frame. Pt also had redness at injection site.
Massive headache for 36 hours, tylenol and advil applied every 4-6 hours, to minimal effect
This spontaneous report was received from a pharmacist via Pfizer (manufacturer control#2015464939) on 30-DEC-2015, referring to a 49 year old male patient with hypertension and coronary artery disease. Another concurrent conditions and medical history were not provided. On 25-OCT-2007, the patient was vaccinated with a dose of PNEUMOVAX 23, 0.5 ml, intramuscular in the left arm (left deltoid), lot number 0697U, expiration date 15-AUG-2009. Concomitant therapies were not reported. The pharmacist mentioned that the patient had swelling of left arm (peripheral swelling) within 24 hour of receiving the injection, that night it was noticed, on 25-OCT-2007. Further, the pharmacist explained that the next he noticed worsening of swelling and redness. So all these started at the night time, the pain, tenderness, redness and swelling. After worsening over night, the next day he was taken to the urgent care the following day (not hospitalized but discharged with prednisone (manufacturer unknown)). None laboratory work was performed. At the time of the report, the outcome of peripheral swelling, erythema, tenderness and pain in extremity was unknown. The reporter did not provide a causality verdict, however he mentioned that the provider considered that the adverse events were related to PNEUMOVAX 23. Batch # 0697U, Lot number 658071/0697U, has been verified to be a valid batch and lot number for PNEUMOVAX 23. Additional information has been requested.
Hospitalized (11.22.21);  COVID-19 positive (11.20.21);  Fully Vaccinated  Diagnosis:  COVID-19, Acute respiratory failure with hypoxia  Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 11/22/2021 Discharge Date: 11/23/2021 DETAILS OF HOSPITAL STAY PRESENTING PROBLEM: Hypoxic [R09.02] COVID-19 [U07.1] Acute respiratory failure with hypoxia [J96.01] HOSPITAL COURSE: Patient is a 66 y.o. male with a past medical history of liver cirrhosis secondary to alcohol abuse, chronic obstructive pulmonary disease, hypertension and obstructive sleep apnea who with hypoxia, COVID-19 positive.  Patient was admitted to the medical service.  He was started on dexamethasone and remdesivir.  His clinical condition improved overnight.  The patient was had no evidence of hypoxia on ambient air.  Vital signs were stable.  He did receive Ativan for tremors thought to be secondary to alcohol withdrawal.  The patient's wife is a nurse.  The patient was discharged on 11/23/2021 in stable condition.  He was asked to return to the hospital if he had worsening fever chills or evidence of hypoxia.
Passed out; broke his wrist; Extremely dizzy; Nauseated; This spontaneous case was reported by a patient family member or friend and describes the occurrence of LOSS OF CONSCIOUSNESS (Passed out) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced LOSS OF CONSCIOUSNESS (Passed out) (seriousness criterion medically significant), WRIST FRACTURE (broke his wrist), DIZZINESS (Extremely dizzy) and NAUSEA (Nauseated). At the time of the report, LOSS OF CONSCIOUSNESS (Passed out), WRIST FRACTURE (broke his wrist), DIZZINESS (Extremely dizzy) and NAUSEA (Nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events ( loss of consciousness, dizziness and nausea), a causal relationship cannot be excluded. Based on reporter's causality the event of Wrist fracture is assessed as unlikely related to mRNA-1273..; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events ( loss of consciousness, dizziness and nausea), a causal relationship cannot be excluded. Based on reporter's causality the event of Wrist fracture is assessed as unlikely related to mRNA-1273..
Moderna covid-19 Vaccine.   Moderna was given to pt Im Left Deltoid 2 10:06 am . during her observation period for 15 min @ 10:20 she complained of itching and red spots on left arm and started on her back until 10:30 when 50 mg of Benadryl given in RD Im .  started itching and red spots on rt arm noted.   no other c/o , no shortness of breath noted, pt alert, oriented x4, sitting in chair talking to husband and drinking water.   11:00 am pt says I am no longer itching, my husband is going to drive me home. Instructed pt if any other symptoms develop go to Hospital ER .  Pt walked out to car with husband to go home. I called pt 3:50 no answer at home number.   spoke to pt at 4:10 pm , she also vomited X1, Slight headache.
Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-418891 (Patient Link).
pt crying since 20min p/vax 22JAN97;cried all evening & noc & t103+ was given APAP alternated w/Ibuprofen q 4-6hr;pt returned to clinic;
Sore arm for 10 days. Flu like symptoms for three days; bedridden for two days. Chills, every joint ached, felt like I was beaten with a baseball bat.
Deep vein thrombosis affecting the left internal jugular, axillary, subclavian and brachial veins.